Literature DB >> 17963214

Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes.

Thomas Pufe1, Wolf Petersen, Fred Fändrich, Deike Varoga, Christoph J Wruck, Rolf Mentlein, Andreas Helfenstein, Daniela Hoseas, Stefanie Dressel, Bernhard Tillmann, Maren Ruhnke.   

Abstract

The focus of this study was a new adult pluripotent cell derived from human peripheral blood monocytes identified as a "programmable cell of monocytic origin" (PCMO). In contrast to bone marrow-derived stem cells, these cells can be harvested from peripheral venous blood without aspiration of the bone marrow and have multilineage potential comparable to that of mesenchymal stem cells (MSC). The aim of this study was to evaluate the potential of PCMOs to differentiate into collagen type II-producing chondrocytes using various extrinsic cues (TGFbeta-1, IGF-1, BMP-2, and BMP-7). Collagen type I and II proteins were localized using immunohistochemistry and quantified by enzyme-linked immunosorbent assays (ELISA). The shape of the differentiating PCMOs was monitored with electron microscopy. Collagen type I and II messenger RNA expression was analyzed using real-time reverse transcriptase-polymerase chain reaction (RT PCR) and regular RT PCR. Immunohistochemistry revealed a strong accumulation of collagen type II after a 6-week incubation period with BMP-2, BMP-7, TGF-beta, IGF-I, and TGF-beta, and IGF-1. Collagen type I was only mildly induced by the applied stimulants. Electron microscopy findings showed a shift from a monocyte-like structure to a chondrocyte-like structure after 2 weeks of stimulation. Stimulation of PCMOs with BMP-2, BMP-7, TGF-beta, IGF-I, and TGF-beta, and IGF-1 induced a chondrogenic differentiation with continuous expression of collagen type II mRNA and protein over several weeks time. Collagen type I and II expression in undifferentiated PCMOs or in control cells incubated without any stimulant was not detected. PCMOs have the potential to differentiate into collagen type II synthesizing chondrocytes. The ability to reprogram and differentiate PCMOs from peripheral blood into sizable quantities might enable their clinical application in cartilage repair after mechanical injury or in cases of osteoarthritis. Copyright 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17963214     DOI: 10.1002/jor.20516

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  14 in total

1.  Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.

Authors:  Catherine H Hackett; Maria Julia B F Flaminio; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

2.  Phenotypic and functional comparison of two distinct subsets of programmable cell of monocytic origin (PCMOs)-derived dendritic cells with conventional monocyte-derived dendritic cells.

Authors:  Babak Beikzadeh; Nowruz Delirezh
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

3.  Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration?

Authors:  Richard Schäfer; Hinnak Northoff
Journal:  Transfus Med Hemother       Date:  2008-05-21       Impact factor: 3.747

4.  Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification.

Authors:  Lars Christian Doehring; Christian Heeger; Zouhair Aherrahrou; Piotr Maciel Kaczmarek; Jeanette Erdmann; Heribert Schunkert; Eva-Maria Ehlers
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

5.  In vitro and in vivo neo-cartilage formation by heterotopic chondrocytes seeded on PGA scaffolds.

Authors:  A Lohan; U Marzahn; K El Sayed; A Haisch; B Kohl; R D Müller; W Ertel; G Schulze-Tanzil; T John
Journal:  Histochem Cell Biol       Date:  2011-06-09       Impact factor: 4.304

6.  Influence of bone morphogenetic protein-2 on the extracellular matrix, material properties, and gene expression of long-term articular chondrocyte cultures: loss of chondrocyte stability.

Authors:  David A Krawczak; Jennifer J Westendorf; Cathy S Carlson; Jack L Lewis
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

7.  Peripheral blood monocytes can differentiate into efficient insulin-producing cells in vitro.

Authors:  A Kyventidis; G Tzimagiorgis; T Didangelos
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 8.  Pathophysiology of the cochlear intrastrial fluid-blood barrier (review).

Authors:  Xiaorui Shi
Journal:  Hear Res       Date:  2016-01-20       Impact factor: 3.208

9.  IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilage.

Authors:  C A Wheeler; S R Jafarzadeh; D M Rocke; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2009-02-15       Impact factor: 6.576

10.  Adipose-derived Human Perivascular Stem Cells May Improve Achilles Tendon Healing in Rats.

Authors:  Sai K Devana; Benjamin V Kelley; Owen J McBride; Nima Kabir; Andrew R Jensen; Se Jin Park; Claire D Eliasberg; Ayelet Dar; Gina M Mosich; Tomasz J Kowalski; Bruno Péault; Frank A Petrigliano; Nelson F SooHoo
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.